#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma Progressive supranuclear palsy Testicular leiomyosarcoma CDKL5 deficiency disorder Malignant oligodendroglioma Choroid melanoma Activated PI3 kinase delta syndrome Peritoneal neoplasm Progressive familial intrahepatic cholestasis Dermatitis Pemphigoid Propionic acidaemia Renal cancer metastatic Thalassaemia beta Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Treatment Sjogren’s syndrome – Treatment Chondrosarcoma metastatic – Basic Information Thrombotic thrombocytopenic purpura – Treatment Mucopolysaccharidosis – Basic Information Rosai-Dorfman syndrome Idiopathic inflammatory myopathy – Diagnostics Alveolar rhabdomyosarcoma – Diagnostics Haemophilia B without inhibitors – Basic Information Krabbe’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Noradrenaline Tartrate Evg321 Ep262 Human Coagulation Factor Viii Retinol Acetate Mirtazapine AUR200 CILOSTAZOL Cctx-001 Diroximel Fumarate Thiocolchicoside Jab-21822 Poloxamer 407 Tafluprost Envudeucitinib Benzyl Alcohol Asp1570 Efinopegdutide Dabigatran Gskvx000000008866 More therapies…

    Learn about Your Condition

    Neck pain Pulmonary congestion Urinary incontinence Sexual dysfunction Adenomyosis Hepatotoxicity Macular degeneration Device related infection Cerebrovascular accident Ureteric cancer Coronary artery occlusion Mantle cell lymphoma recurrent Brain injury Renal cancer recurrent Myxoid liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Head and neck cancer

  • Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Italy

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Neuroendocrine carcinoma of the skin
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Avelumab
    • Atezolizumab
    • Cemiplimab
    France

  • Study on Capsaicin Patch and Amitriptyline for Neuropathic Pain in Head and Neck Cancer Patients in Remission

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Amitriptyline
    • Capsaicin
    France

  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    • Diffuse large B-cell lymphoma
    • Cervix carcinoma
    Investigated Drugs:
    • Tolinapant Lactate
    Italy Spain

  • Study on Using Cetuximab with Fluorescence Endoscopy to Find Primary Tumors in Patients with Unknown Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cetuximab
    The Netherlands

  • Study of NBTXR3 and Cetuximab with Radiotherapy for Elderly Patients with Advanced Head and Neck Cancer Not Eligible for Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cetuximab
    Czechia Germany Greece
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!